Overview

Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults

Status:
Completed

Trial end date:
2016-04-01

Target enrollment:

Participant gender:

Summary

This study is the first study in humans with CVT-427 (zolmitriptan inhalation powder) and is designed to evaluate the safety, tolerability, and PK of single ascending doses of CVT-427 in adult healthy volunteers.

Phase:

Phase 1

Details

Lead Sponsor:

Acorda Therapeutics

Treatments:

Oxazolidinones
Zolmitriptan